Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

Issue : The Pharmaceutical Journal, 3/10 January 2015, Vol 294, No 7843/4

Sort by: Newest first Oldest first A-Z Z-A

  • Xtandi new indication Subscription

    17 DEC 2014 16:58

    Xtandi (enzalutamide; Astellas) is now indicated for the treatment of adult men with metastatic castration-resistant prostate cancer who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated, according to the updated summary of product characteristics. Xtandi was previously only indicated for the treatment of adult men with metastatic castration-resistant prostate cancer whose disease has progressed ...

  • Whooping cough vaccines could lose their effectiveness Subscription

    30 DEC 2014 18:43

    Scientists are warning that current whooping cough vaccines may not be able to control the disease in future.

  • Wednesday 21 January: Gloucestershire Subscription

    5 JAN 2015 15:51

    Local practice forum event, ‘Pharmacy Organisations Update’. Sandford Education Centre, Cheltenham GL53 7PX. Event 7.30pm, buffet 6.30pm. Book via the RPS website. Contact by 6pm on 14 January 2015 to book food.    

  • Walgreens’ shareholders approve merger with Alliance Boots Subscription

    30 DEC 2014 18:38

    Shareholders of the US pharmacy chain Walgreens have voted in favour of the company’s merger with Alliance Boots after a special meeting on 29 December 2014.

  • x-ray of intestinal abdominal 14

    US approves new antibiotic for life-threatening infections Subscription

    22 DEC 2014 16:37

    The US Food and Drug Administration (FDA) has approved the use of a new antibiotic, ceftolozane plus tazobactam (Zerbaxa), for the treatment of adults with complicated intra-abdominal infections and complicated urinary tract infections.

  • Tuesday 27 January: NW London Subscription

    5 JAN 2015 15:50

    Local practice forum event, ‘Chronic obstructive pulmonary disease workshop – resources, inhalers and devices to support patients’. Best Western Cumberland Hotel, 1–3 St Johns Road, Harrow HA1 2EF. Event 7.45pm, buffet 7pm. Book via the RPS website.

  • Tuesday 27 January: Newport Subscription

    12 DEC 2014 12:30

    A Wales Centre for Pharmacy Professional Education (WCPPE) event, held jointly with the Royal Pharmaceutical Society, ‘Annual Professional Debate’. Hilton Hotel, Chepstow Road, Langstone, Newport NP18 2LX. Event 7pm. Book via WCPPE by calling 029 2087 4784 or via

  • Tuesday 13 January: SW London Subscription

    10 DEC 2014 11:06

    Local practice forum event, ‘Centre for Pharmacy Postgraduate Education diabetes focal point’. Postgraduate Centre, Croydon University Hospital, 530 London Road, Croydon, Surrey CR7 7YE. Event 7.30pm, buffet 7pm. Email to book.

  • The UN Millennium Development Goals may have fallen short, but it has created a strong foundation for ending health inequality

    The next step for the UN's Millennium Development Goals Subscription

    8 JAN 2015

    The UN Millennium Development Goals may have fallen short of their aims, but they have created a strong foundation for ending health inequality.

  • The deep-fried Mars bar: an illustration of a bad diet?

    1 DEC 2014 By Pamela Mason

    After analysing a small study in healthy young adults, which found that eating deep-fried Mars bar caused a significant impairment in cerebrovascular reactivity in men, Pam Mason advises sticking to porridge for breakfast.

Show  10 per page20 per page50 per page

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.